MedPath

Youth Partners in Care: Depression and Quality Improvement

Not Applicable
Completed
Conditions
Depression
Interventions
Other: Usual Care
Other: Quality Improvement (QI) for depression
Registration Number
NCT02030782
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Brief Summary

This randomized effectiveness trial evaluates a quality improvement intervention aimed at providing access to evidence-based depression treatments (particularly cognitive-behavior therapy for depression and or pharmacotherapy) through primary care for youth ages 13-21, as compared to enhanced usual care. The major hypothesis is that the quality improvement intervention will be associated with improved outcomes, relative to enhanced usual care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
418
Inclusion Criteria
  • Met either of two criteria: 1) endorsed "stem items" for major depression or dysthymia from the 12-month Composite International Diagnostic Interview(CIDI-12,2.1) modified slightly to conform to diagnostic criteria for adolescents, 1-week or more of past-month depressive symptoms, and a total Center for Epidemiological Studies- Depression Scale(CES-D)40 score ≥ 16, or 2) CES-D score ≥ 24.
  • Age 13-21
  • Presented at primary care clinic
Exclusion Criteria
  • not English-speaking
  • provider not in study
  • sibling already in study
  • completed eligibility screener previously

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual CareUsual CarePatients received usual care through primary care, enhanced by provider education regarding depression evaluation and management (1-2 hour training, plus study manual)
Quality Improvement for DepressionQuality Improvement (QI) for depressionMajor intervention components included a) expert leader teams who planned and implemented the intervention at each clinic, b) care managers who supported primary care clinicians with depression evaluation and management, c) access to cognitive-behavior therapy for depression within each primary care clinic, and d) patient and provider choice regarding treatment modality.
Primary Outcome Measures
NameTimeMethod
Self-reported depressive symptoms on the CES-D (Center for Epidemiologic Studies Depression Scale)6-months
Secondary Outcome Measures
NameTimeMethod
satisfaction with care6 months with follow up at 12 and 18 months
mental health related quality of life as assessed using self-report on the Medical Outcomes Study Short Form 12 Health Survey.6 months, with follow up at 12 and 18 months
Rates of mental health care, counseling/psychotherapy, and medication treatment.6-months with follow-up at 12 and 18 months

Youth self report on the study version of the Service Assessment for Children \& Adolescents provided measures of rates of mental health care(dichotomous indicator of whether any mental health treatment received), counseling/psychotherapy (dichotomous indicator of whether counseling/psychotherapy was received, number of counseling/psychotherapy sessions), and medication treatment (dichotomous indicator of whether youth received any medication treatment for mental health problems). These measures were obtained using .

Trial Locations

Locations (5)

Kaiser Permanente Los Angeles Medical Center

🇺🇸

Los Angeles, California, United States

University of California

🇺🇸

Los Angeles, California, United States

Venice Family Clinic

🇺🇸

Venice, California, United States

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

Ventura County Medical Center

🇺🇸

Ventura, California, United States

© Copyright 2025. All Rights Reserved by MedPath